Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chassagne

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Anticancer Research|August 11, 2001
Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosasD J Bernard-Gallon, M Peffault de Latour, C Hizel, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Anticancer Research|August 11, 2001
Localization of human BRCA1 and BRCA2 in non-inherited colorectal carcinomas and matched normal mucosasD J Bernard-Gallon, M Peffault de Latour, C Hizel, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.
Pageof 7